FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Novel Drug Approvals Remain Steady in 2026 First Half

FDA approval numbers show it approved 23 novel drugs during the first six months of 2026, maintaining a pace that would be consistent with recent year...

latest-news-card-1
Human Drugs

FDA Selects 7 PreCheck Pilot Participants

FDA selects seven companies from 80 applications to participate in the agencys PreCheck Pilot Program to advance U.S. drug manufacturing.

latest-news-card-1
Human Drugs

Genzyme Ireland Inspection Documents CGMP Issue

FDA warns Genzyme Ireland about the failure of the firms quality control unit to ensure that drugs comply with CGMP requirements.

latest-news-card-1
Biologics

Former CDC Official Alleges Political Interference In Vaccine Policy

During a CBS News interview, former CDC chief medical officer Debra Houry says she left the agency after concluding she could no longer defend its sci...

latest-news-card-1
FDA General

Insufficient Data on 7 Peptides for Potential Compounding Use: FDA

FDA briefing materials show that agency reviewers have found limited evidence supporting the safety and effectiveness of seven peptide substances that...

latest-news-card-1
Marketing

FDA Sued Over Rejection of Supplement Ad Claims

Three Benesh Friedlander Coplan & Aronoff attorneys say a suit against FDA filed by the Alliance for Natural Health USA could change the way that supp...

latest-news-card-1
Human Drugs

Next-Generation Sequencing Data Submission Guidance

FDA publishes a guidance on submitting next-generation sequencing data to CDERs Division of Antivirals.

latest-news-card-1
Human Drugs

CGMP Issues at Indias Wizcure Pharmaa

FDA warns Indias Wizcure Pharmaa about CGMP violations in its production of over-the-counter drugs.

latest-news-card-1
Human Drugs

Complete Response on Liver Imaging Agent

FDA sends Ascelia Pharma a Complete Response Letter regarding its NDA for Orviglance, a contrast agent for liver imaging.

Human Drugs

OIG Backs Manufacturer-Sponsored Patient Tests

Two Sheppard attorneys discuss an HHS Inspector General advisory opinion backing a drug companys arrangement with a third-party laboratory for free an...